<p>Comparison of the main clinical parameters between baseline and during follow-up (or at final follow-up) in all patients and among PTBMIL groups.</p
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
<p>Baseline characteristics comparison between the alive or deceased dialysis patients during the fo...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Clinical parameters of the two study groups at the baseline and during follow-up.</p
Comparisons of baseline characteristics and clinical courses of the patient groups.</p
<p>(A) Comparison of hemodynamic parameters of study subjects at baseline. (B) Comparison of hemodyn...
<p>Comparison of baseline clinical characteristics according to success of half-dose PDT.</p
Treatment parameters of the two study groups at the baseline and during follow-up period.</p
Baseline versus post-treatment characteristics in relation to clinical response.</p
<p>** Significant at a level of 0.01 by paired t-test or independent t-test as appropriate</p><p>Com...
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Comparison of patient clinical characteristics and BPV in the groups with and without END.</p
Comparison of baseline characteristics of participants and non-participants in the follow-up of the ...
<p>Comparison of the baseline characteristics of the screening and clinical detection groups.</p
<p>Comparison of baseline parameters between subjects with remitted and sustained NAFLD.</p
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
<p>Baseline characteristics comparison between the alive or deceased dialysis patients during the fo...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Clinical parameters of the two study groups at the baseline and during follow-up.</p
Comparisons of baseline characteristics and clinical courses of the patient groups.</p
<p>(A) Comparison of hemodynamic parameters of study subjects at baseline. (B) Comparison of hemodyn...
<p>Comparison of baseline clinical characteristics according to success of half-dose PDT.</p
Treatment parameters of the two study groups at the baseline and during follow-up period.</p
Baseline versus post-treatment characteristics in relation to clinical response.</p
<p>** Significant at a level of 0.01 by paired t-test or independent t-test as appropriate</p><p>Com...
<p>Comparison of demographic, medication, treatments, and clinical characteristics between those wit...
Comparison of patient clinical characteristics and BPV in the groups with and without END.</p
Comparison of baseline characteristics of participants and non-participants in the follow-up of the ...
<p>Comparison of the baseline characteristics of the screening and clinical detection groups.</p
<p>Comparison of baseline parameters between subjects with remitted and sustained NAFLD.</p
Comparison of clinical characteristics between the DAS and US remission groups and the non-remission...
<p>Baseline characteristics comparison between the alive or deceased dialysis patients during the fo...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...